These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15791692)

  • 21. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion.
    Fischer M; Bhatnagar J; Guarner J; Reagan S; Hacker JK; Van Meter SH; Poukens V; Whiteman DB; Iton A; Cheung M; Dassey DE; Shieh WJ; Zaki SR
    N Engl J Med; 2005 Dec; 353(22):2352-60. PubMed ID: 16319384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.
    Tang OS; Chan CC; Kan AS; Ho PC
    Hum Reprod; 2005 Nov; 20(11):3062-6. PubMed ID: 16037110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate and misoprostol to terminate early pregnancy.
    Perrone J; Hoffman RS
    N Engl J Med; 1996 Feb; 334(6):399; author reply 400. PubMed ID: 8538715
    [No Abstract]   [Full Text] [Related]  

  • 26. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion.
    Cohen AL; Bhatnagar J; Reagan S; Zane SB; D'Angeli MA; Fischer M; Killgore G; Kwan-Gett TS; Blossom DB; Shieh WJ; Guarner J; Jernigan J; Duchin JS; Zaki SR; McDonald LC
    Obstet Gynecol; 2007 Nov; 110(5):1027-33. PubMed ID: 17978116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
    Li CL; Wei M; Fu MF; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):542-5. PubMed ID: 17983494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure.
    Stockheim D; Machtinger R; Wiser A; Dulitzky M; Soriano D; Goldenberg M; Schiff E; Seidman DS
    Fertil Steril; 2006 Oct; 86(4):956-60. PubMed ID: 17027362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.
    Lohr PA; Reeves MF; Hayes JL; Harwood B; Creinin MD
    Contraception; 2007 Sep; 76(3):215-20. PubMed ID: 17707719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Misoprostol and pregnancy: risk of malformations.
    Prescrire Int; 2008 Apr; 17(94):65-6. PubMed ID: 18516817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
    Heikinheimo O; Leminen R; Suhonen S
    Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-administration of vaginal misoprostol after mifepristone for termination of pregnancy: patient acceptability.
    Kiran U; Amin P; Penketh RJ
    J Obstet Gynaecol; 2006 Oct; 26(7):679-81. PubMed ID: 17071439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
    Esteve JL; Gallego FG; Llorente MP; Bermúdez SB; Sala ES; González LV; Texidó CS
    Contraception; 2008 Jul; 78(1):52-60. PubMed ID: 18555818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bleeding after medication-induced termination of pregnancy with two dosing schedules of mifepristone and misoprostol.
    Chen AY; Mottl-Santiago J; Vragovic O; Wasserman S; Borgatta L
    Contraception; 2006 Apr; 73(4):415-9. PubMed ID: 16531178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of parity in medical abortion up to 49 days of amenorrhoea.
    Lefebvre P; Cotte M; Monniez N; Norel G
    Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):404-11. PubMed ID: 19117257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.
    Jansen NE; Pasker-De Jong PC; Zondervan HA
    J Matern Fetal Neonatal Med; 2008 Nov; 21(11):847-51. PubMed ID: 18979392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.